Aimovig 140 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB25FSGDB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,028
Award facts
- Contract value 100% obligated
- $22,028.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,028.28 to AmerisourceBergen Drug Corp for the supply of AIMOVIG 140 mg/ml autoinjectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 29, 2025. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal contract awards predominantly with the Defense Logistics Agency and its Medical Supply Chain. The company demonstrates significant capability in fulfilling federal medical procurement requirements through competitive awards across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue serving critical healthcare customers including the Defense Health Agency and U.S. Coast Guard through this flexible contract framework.
Quick answers
Who was awarded contract SPE2DB25FSGDB?
SPE2DB25FSGDB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FSGDB worth?
The government has obligated $22,028 on SPE2DB25FSGDB.
Is contract SPE2DB25FSGDB an order under another contract?
Yes. SPE2DB25FSGDB is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSGDB competed?
The extent of competition for SPE2DB25FSGDB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award